SQLite Web: event_store.db

Update row 39537 in events

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-14T02:04:49.876253+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:2085edd3eedfda8f","evidence_event_ids":["evt_165fa39cf3a7"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001214659-26-004601.txt","as_of":"2026-04-14T02:04:49.876253+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001214659-26-004601.txt","company":"Twist Bioscience Corp","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001214659-26-004601.txt","article_chars":1912,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_fa7d246cb90f2ae9","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001214659-26-004601.txt","content_type":"text/plain","enriched_at":"2026-04-14T02:18:31.948561+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001214659-26-004601.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001214659-26-004601.txt","source_event_id":"evt_165fa39cf3a7","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"9f52ce8520ed277e","kind":"sec_filing","published_at":"20260413","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.62,"dates_mentioned":["2026-04-13","2026-04-09"],"entities":[{"asset_class":"equity","name":"Twist Bioscience Corp","relevance":"high","symbol":"TWST","type":"issuer"},{"asset_class":"person","name":"Adam Laponis","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"person","name":"Kendra Fox","relevance":"medium","symbol":"","type":"attorney_in_fact"}],"event_type":"listing","information_gaps":["The signal indicates a \u201cdelta\u201d vs prior known state, but no prior state/details are provided here, so the exact change vs prior filings cannot be determined.","The cleaned text does not explicitly state whether the Form 4 includes additional transactions beyond the \u201csell to cover\u201d described.","The exact mapping of numeric fields (e.g., whether 49.889 is sale price per share and whether 125694 is total proceeds) is not explicitly labeled in the provided text."],"key_facts":["SEC accession number: 0001214659-26-004601.","Form type: 4.","Issuer: Twist Bioscience Corp (TWST).","Reporting person: Adam Laponis (listed as Chief Financial Officer).","Period of report (conformed period of report): 2026-04-09.","Filed as of date / date as of change: 2026-04-13.","The filing states the transaction is a \u201csell to cover\u201d to satisfy tax withholding obligations in connection with vesting of Restricted Stock Units.","The filing includes a disclosed share quantity: 2,597 shares (shown as \u201c2597\u201d).","The filing includes a price/amount field: 49.889 (shown as \u201c49.889 D\u201d).","The filing includes a total/other numeric field: 125694 (shown as \u201c125694 D\u201d)."],"numeric_claims":[{"label":"shares (sell to cover)","value":"2597"},{"label":"price field shown","value":"49.889"},{"label":"numeric total/other field shown","value":"125694"}],"primary_claim":"Form 4 for Twist Bioscience Corp was filed on 2026-04-13 (period of report 2026-04-09) by Adam Laponis, disclosing shares sold to cover tax withholding for vested RSUs.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Twist Bioscience Corp (TWST) filed a Form 4 on 2026-04-13 for reporting period 2026-04-09 by CFO Adam Laponis. The filing discloses a \u201csell to cover\u201d transaction of shares to satisfy tax withholding obligations related to vesting of RSUs.","topics":["SEC Form 4","insider transaction","sell to cover","tax withholding","RSUs","equity incentive plan"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Twist Bioscience Corp \u00b7 Filed 20260413","ticker":"TWST","tickers":["TWST"],"title":"TWST filed 4","url":"https://www.sec.gov/Archives/edgar/data/1581280/0001214659-26-004601.txt"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel